The development of modern pharmaceuticals is a testament to intricate chemical synthesis, where specific intermediates act as crucial stepping stones. Baricitinib, a successful JAK inhibitor used for treating rheumatoid arthritis and other inflammatory conditions, is a prime example of such a complex molecule. At its core, the synthesis of Baricitinib relies on high-quality precursors, with 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile (CAS: 1187595-85-2) being a particularly vital one. Understanding the chemistry and supply of this intermediate is key for efficient drug manufacturing.

The molecular structure of 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile presents a unique combination of functional groups that are instrumental in building the Baricitinib molecule. The azetidine ring, substituted with an ethylsulfonyl group and an acetonitrile unit, provides the necessary framework for subsequent chemical transformations. As a white powder, its physical properties are consistent with many fine chemicals used in pharmaceutical synthesis, and its typical purity of 98% or higher ensures that the complex synthetic pathways are not compromised by impurities.

For pharmaceutical researchers and manufacturers, sourcing this intermediate reliably is essential. Our role as a Chinese chemical supplier is to ensure that this demand is met with quality products and efficient delivery. When you choose to buy 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile from us, you are engaging with a manufacturer that understands the stringent requirements of the pharmaceutical industry. We provide detailed technical specifications and support, helping to streamline your R&D and production processes.

The cost-effectiveness associated with manufacturing in China also plays a role in the global pharmaceutical supply chain. By leveraging our manufacturing capabilities, we can offer competitive pricing for 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile, making it more accessible for companies of all sizes. This allows for greater budget flexibility, particularly for companies engaged in extensive clinical trials or large-scale manufacturing.

In essence, the journey from raw materials to a finished API like Baricitinib is a complex chemical endeavor. The quality and availability of intermediates such as CAS 1187595-85-2 are fundamental to this process. We are proud to be a reliable supplier, contributing to the advancement of pharmaceutical therapies by providing the essential chemical building blocks that power innovation. We encourage you to contact us to inquire about purchasing this critical intermediate.